Seeking Alpha

In its conference call, Allergan (AGN) says it's exploring strategic options for its obesity...

In its conference call, Allergan (AGN) says it's exploring strategic options for its obesity intervention business,including a potential sale of the business unit. If it does pursue that option however, the company adds that it intends to offset any potential earnings dilution related to the transaction.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs